Useful in the evaluation of patients with suspected diseases associated with elevations in total immunoglobulin E (IgE) including allergic disease, primary immunodeficiencies, infections, malignancies, or other inflammatory diseases. Also used as a diagnostic evaluation of patients with suspected allergic bronchopulmonary aspergillosis, and the identification of candidates for omalizumab (anti-IgE) therapy
Serum
SST (1)
Plasma
EDTA (1)
REFRIGERATE (7 Days)
4 Days
Fluorescent Enzyme Immunoassay
82785
IgE, Immunoglobulin E, Immune Competence, Total IgE
Detects antibodies floating freely in the blood that could act against certain red blood cells. Used to diagnose potential reactions to a blood transfusion.
Useful for predicting the future development of type 1 diabetes in asymptomatic children, adolescents, and young adults when used in conjunction with family history, HLA-typing, and other autoantibodies, including GD65S/81596 Glutamic Acid Decarboxylase (GAD65) Antibody Assay, and serum and islet cell antigen 2 (IA-2) antibodies. Used for differential diagnosis of type 1 versus type 2 diabetes, for evaluating diabetics with insulin resistance in patients with established diabetes (type 1 or type 2), and for the investigation of hypoglycemia in nondiabetic subjects.
Useful for evaluation of growth disorders, growth hormone deficiency or excess in children and adults, monitoring of recombinant human growth hormone treatment, and follow-up of individuals with acromegaly and gigantism.
Useful for diagnosis of growth disorders, for diagnosing adult growth hormone deficiency, for monitoring of recombinant human growth hormone treatment, and as a possible adjunct to insulin-like growth factor 1 and growth hormone in the diagnosis and follow-up of acromegaly and gigantism.
Useful for the determination of iodine overload using serum specimens, and monitoring iodine levels in individuals taking iodine-containing drugs.
Serum
Dark Blue Trace Element (1)
None
None
Do not use iodine disinfectant during draw. Do not collect if PT has been administered gadolinium or iodine-containing contrast media in past 96 HR. Must use metal free vials and collection tubes. Do not pipette.